Neonatal jaundice overview: Difference between revisions
Megan Merlo (talk | contribs) No edit summary |
Megan Merlo (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
{{ | {{PleaseHelp}} | ||
==Overview== | ==Overview== |
Revision as of 15:31, 15 July 2016
Neonatal jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neonatal jaundice overview On the Web |
American Roentgen Ray Society Images of Neonatal jaundice overview |
Risk calculators and risk factors for Neonatal jaundice overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Neonatal jaundice is a yellowing of the skin and other tissues of a newborn infant caused by increased levels of bilirubinin the blood.
A bilirubin level of more than 85 umol/l (5 mg/dL) manifests clinical jaundice in neonates whereas in adults a level of 34 umol/l (2 mg/dL) would look icteric. In newborns jaundice is detected by blanching the skin with digital pressure so that it reveals underlying skin and subcutaneous tissue. Jaundice newborns have an apparent icteric sclera, and yellowing of the face, extending down onto the chest.
In neonates the dermal icterus is first noted in the face and as the bilirubin level rises proceeds caudal to the trunk and then to the extremities.[1]
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neonatal jaundice from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
References
- ↑ Madlon-Kay, Diane J. Recognition of the Presence and Severity of Newborn Jaundice by Parents, Nurses, Physicians, and Icterometer Pediatrics 1997 100: e3